This country profile provides an overview of Senegal’s progress in reaching those in need of mass NTD treatment based on 2019 data.
*This includes all countries in Africa that are endemic for at least one of the five NTDs
Treatment coverage
Elephantiasis
68%
Blinding trachoma
N/A
Intestinal worms
70%
Bilharzia
76%
River blindness
26%
6.16 million
people received treatment in Senegal in 2019
2.66 million
people did not receive treatment in Senegal in 2019
Elephantiasis
Treatment coverage increased from 62% in 2018 to 68% in 2019.
People needing treatment
8.82m
People receiving treatment
6.01m
Blinding trachoma
Senegal is conducting post-preventive chemotherapy surveillance.
Intestinal worms
Treatment coverage increased from 34% in 2018 to 70% in 2019.
Pre-sch and school-aged children needing treatment
1.08m
Pre-school and school-aged children receiving treatment
758k
Bilharzia
Treatment coverage increased from 67% in 2018 to 76% in 2019.
School-aged children needing treatment
1.92m
School-aged children receiving treatment
1.46m
River blindness
Treatment coverage decreased from 94% in 2018 to 26% in 2019.
People needing treatment
723k
People receiving treatment
190k
The 
ESPEN portal (a World Health Organization AFRO region project) provides maps and district-level data for the preventive chemotherapy diseases in Senegal.